Bococizumab is a cutting-edge anti-PCSK9 antibody efficiently developed to treat hypercholesterolemia. It therapeutic agent functions through the PCSK9 protein, a key regulator of cholesterol amounts. By inhibiting the https://www.targetmol.com/compound/bococizumab